Compounds > 2,2-bis(4-glycidyloxyphenyl)propane
Page last updated: 2024-10-23

2,2-bis(4-glycidyloxyphenyl)propane and Kidney Neoplasms

2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Kidney Neoplasms in 2 studies

2,2-bis(4-glycidyloxyphenyl)propane: structure

Kidney Neoplasms: Tumors or cancers of the KIDNEY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mahmoud, MF1
El Shazly, SM1
Peristianis, GC1
Doak, SM1
Cole, PN1
Hend, RW1

Other Studies

2 other studies available for 2,2-bis(4-glycidyloxyphenyl)propane and Kidney Neoplasms

ArticleYear
Pioglitazone protects against cisplatin induced nephrotoxicity in rats and potentiates its anticancer activity against human renal adenocarcinoma cell lines.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2013, Volume: 51

    Topics: Animals; Benzhydryl Compounds; Carcinoma, Renal Cell; Cell Line, Tumor; Cisplatin; Epoxy Compounds;

2013
Two-year carcinogenicity study on three aromatic epoxy resins applied cutaneously to CF1 mice.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 1988, Volume: 26, Issue:7

    Topics: Administration, Topical; Animals; Benzhydryl Compounds; Epoxy Compounds; Ethers, Cyclic; Female; Kid

1988